Table 3 Ventilatory support data during the study period; data are presented as number (%) or mean (SD)
From: Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus
Day 1 | Day 3 | Day 7 | Day 10 | Day 14 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
ECMO (n = 17) | Non-ECMO (n = 18) | ECMO (n = 14) | Non-ECMO (n = 15) | ECMO (n = 14) | Non-ECMO (n = 15) | ECMO (n = 14) | Non-ECMO (n = 15) | ECMO (n = 14) | Non-ECMO (n = 14) | |
Invasive ventilation n (%) | 17 (100%) | 18 (100%) | 14 (100%) | 16 (100%) | 14 (100%) | 15 (100%) | 11 (78.6%) | 14 (93.3%) | 5 (35.7%) | 13 (92.9%)* |
Mode of ventilation | ||||||||||
CMV | 6 (35.3%) | 10 (55.6%) | 7 (50%) | 11 (68.8%) | 6 (42.8%) | 8 (53.3%) | 4 (36.4%) | 6 (42.9%) | 1 (20%) | 11 (84.6%)* |
PCV | 3 (17.6%) | 2 (11.1%) | 4 (28.6%) | 1 (6.3%) | 4 (28.5%) | 3 (20%) | 3 (27.3%) | 5 (35.7%) | 3 (60%) | 0 (0%)* |
VCV | 4 (23.5%) | 4 (22.2%) | 1 (7.1%) | 2 (12.5%) | 1 (7.1%) | 1 (6.7%) | 1 (9.1%) | 2 (14.3%) | 1 (20%) | 0 (0%) |
PRVC | 2 (11.8%) | 1 (5.6%) | 3 (21.4%) | 0 (0%) | 1 (7.1%) | 2 (13.3%) | 0 (0%) | 1 (7.1%) | 0 (0%) | 1 (7.7%) |
APRV | 1 (6.7%) | 1 (5.6%) | 1 (7.1%) | 0 (0%) | 1 (7.1%) | 1 (6.7%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (7.7%) |
SIMV | 1 (5.9%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (9.1%) | 0 (0%) | 0 (0%) | 0 (0%) |
PSV | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (9.1%) | 0 (0%) | 0 (0%) | 0 (0%) |
CPAP | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (9.1%) | 0 (0%) | 0 (0%) | 0 (0%) |
HFOV | 0 (0%) | 0 (0%) | 0 (0%) | 1 (6.3%) | 1 (7.1%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
FiO2 (%) | 0.67 (0.29) | 0.80 (0.24) | 0.59 (0.24) | 0.79 (0.25)* | 0.50 (0.21) | 0.73 (0.24)* | 0.50 (0.25) | 0.66 (0.27) | 0.33 (0.17) | 0.72 (0.38)* |
PaO2/FiO2 ratio (%) | 115 (110.2) | 109 (93.9) | 109 (81.51) | 63 (62.7) | 124 (106.9) | 63 (66.1)* | 138 (139.5) | 36 (66.4)* | 237 (42.11) | 85 (31.95)* |
PEEP (cm H2O) | 12 (3.97) | 12 (6.4) | 13 (3.94) | 14 (4.8) | 11 (3.61) | 14 (5.6) | 11 (4.04) | 11 (5.7) | 10 (7.20) | 13 (7.0) |
Use of NMBs n (%) | 8 (53.3%) | 12 (66.7%) | 10 (76.9%) | 12 (80%) | 10 (71.4) | 8 (53.3%) | 4 (36.4%) | 3 20%) | 2 (40%) | 0 (0%) |